Rossi C, Andre M, Dupuis J, Morschhauser F, et al. High-risk stage IIB Hodgkin lymphoma treated in the H10 and AHL2011 trials: TMTV is a useful risk factor to stratify patients at baseline. Haematologica 2022 May 31. doi: 10.3324/haematol.2021.280004.
PMID: 35638548